Company · founded 1965

Charles River Associates

Boston, United States · charlesriverassociates.com

Manage this page

Citations, last 5 years: 680
Works, last 5 years: 184
h-index: 83
Scientists listed: 13
Grants since 2016: 1 402

Grants received

2022–2026 · research · R01

Precise targeting of T1D specific T cells using CAR and peptide-MHC chimeric antigen ligands

Michael Birnbaum · Charles River Associates · funded by National Institutes of Health

$728.5kCAR-T cell therapy research

2022–2027 · research · R01

Arthroscopic Raman Monitoring of Cartilage Content for PTOA Diagnosis and Chondroregenerative Treatment Response

Michael B Albro · Charles River Associates · funded by National Institutes of Health

$502.7kOsteoarthritis Treatment and Mechanisms

2022–2027 · research · R01

Cerebrovascular Remodeling and Neurodegenerative Changes in Alzheimer's Disease

Thor Stein · Charles River Associates · funded by National Institutes of Health

$807.7k

2022–2027 · research · R01

Functional heterogeneity of vasoactive intestinal peptide-expressing interneurons in the anterior cingulate cortex

Alberto Cruz-Martin · Charles River Associates · funded by National Institutes of Health

$412.5kNeuroendocrine regulation and behavior

2022–2027 · career development · K23

Reducing psychological barriers to PrEP persistence among pregnant and postpartum women in Cape Town, South Africa

Amelia M. Stanton · Charles River Associates · funded by National Institutes of Health

$188.7kHIV/AIDS Research and Interventions

2022–2026 · research · R01

Sulfated Poly-Amido-Saccharide (sulPAS) Biomaterials as Anticoagulants

Elliot Chaikof · Charles River Associates · funded by National Institutes of Health

$551.2kProteoglycans and glycosaminoglycans research

2022–2026 · research · R01

Precise targeting of T1D specific T cells using CAR and peptide-MHC chimeric antigen ligands

Michael Birnbaum · Charles River Associates · funded by National Institutes of Health

$674.6kCAR-T cell therapy research

2022–2025 · fellowship · F31

Predictors of Speech Motor Sequence Learning in Neurological Disorders

Hilary Elizabeth Miller · Charles River Associates · funded by National Institutes of Health

$45.9k

2022–2024 · fellowship · F32

Effect of producing a desired fundamental frequency on measures of vocal hyperfunction in transgender speakers

Nichole Houle · Charles River Associates · funded by National Institutes of Health

$69.5kVoice and Speech Disorders

2022–2026 · research · R01

Biodegradable, Biocompatible Pressure Sensitive Adhesives

Yolonda L Colson · Charles River Associates · funded by National Institutes of Health

$555.6kPleural and Pulmonary Diseases

2022–2027 · research · R01

The Conundrum of Absentee Receptors: Efficacy Potentiation Through Drug-Receptor Modulation

Mark W. Grinstaff · Charles River Associates · funded by National Institutes of Health

$652.8kPregnancy-related medical research

2022–2025 · fellowship · F31

Poly(glycerol carbonate) pressure sensitive adhesives for the in vivo closure of alveolar pleural fistulae

Danielle Fitzgerald · Charles River Associates · funded by National Institutes of Health

$46.8kPleural and Pulmonary Diseases

2022–2025 · fellowship · F32

Sensory and Control Mechanisms of Temporal Attention

Michael Lewis Epstein · Charles River Associates · funded by National Institutes of Health

$76.8k

2022–2027 · research · R01

Linking Motor Cortex Activity and Movement in the Mouse Orofacial System

Michael Nicholas Economo · Charles River Associates · funded by National Institutes of Health

$400.1k

2022–2026 · research · R01

Sulfated Poly-Amido-Saccharide (sulPAS) Biomaterials as Anticoagulants

Elliot Chaikof · Charles River Associates · funded by National Institutes of Health

$553.8kProteoglycans and glycosaminoglycans research

2022–2025 · fellowship · F32

Sensory and Control Mechanisms of Temporal Attention

Michael Lewis Epstein · Charles River Associates · funded by National Institutes of Health

$69.5k

2022–2027 · research · R01

Cerebrovascular Remodeling and Neurodegenerative Changes in Alzheimer's Disease

Thor Stein · Charles River Associates · funded by National Institutes of Health

$825k

2022–2025 · fellowship · F32

A Scalable Method for Mapping Microconnectivity in Transcriptomically Distinct Neuron Types

Maria Victoria Moya · Charles River Associates · funded by National Institutes of Health

$69.8k

2022–2027 · research · R35

Probing co-transcriptional gene regulatory logics in human transcriptomes

Ana Fiszbein · Charles River Associates · funded by National Institutes of Health

$412.5k

2022–2024 · fellowship · F32

Effect of producing a desired fundamental frequency on measures of vocal hyperfunction in transgender speakers

Nichole Houle · Charles River Associates · funded by National Institutes of Health

$69.9kVoice and Speech Disorders

2022–2026 · research · R01

Sulfated Poly-Amido-Saccharide (sulPAS) Biomaterials as Anticoagulants

Elliot Chaikof · Charles River Associates · funded by National Institutes of Health

$562.5kProteoglycans and glycosaminoglycans research

2022–2025 · fellowship · F32

A Scalable Method for Mapping Microconnectivity in Transcriptomically Distinct Neuron Types

Maria Victoria Moya · Charles River Associates · funded by National Institutes of Health

$73.8k

2022–2024 · fellowship · F32

A Scalable Method for Mapping Microconnectivity in Transcriptomically Distinct Neuron Types

Maria Victoria Moya · Charles River Associates · funded by National Institutes of Health

$6 201

2022–2026 · research · R01

Optimization and validation of quantitative birefringence microscopy for assessment of myelin pathologies associated with cognitive impairments and motor deficits in young and old aging monkey brain

Irving J. Bigio · Charles River Associates · funded by National Institutes of Health

$559.1k

2022–2025 · fellowship · F31

Predictors of Speech Motor Sequence Learning in Neurological Disorders

Hilary Elizabeth Miller · Charles River Associates · funded by National Institutes of Health

$47.2k

2022–2025 · research · R00

Developmental Engagement of Neural Circuitry Underlying Safety Learning

Heidi Catherine Meyer · Charles River Associates · funded by National Institutes of Health

$249kMemory and Neural Mechanisms

2022–2027 · research · R01

Cerebrovascular Remodeling and Neurodegenerative Changes in Alzheimer's Disease

Thor Stein · Charles River Associates · funded by National Institutes of Health

$789.9k

2022–2027 · research · R01

Neurophotonic Advances for Mechanistic Investigation of the Role of Capillary Dysfunction in Stroke Recovery

David A Boas · Charles River Associates · funded by National Institutes of Health

$693.7k

2022–2027 · training · T32

Training Program in Quantitative Biology & Physiology (QBP)

John A. White · Charles River Associates · funded by National Institutes of Health

$520.4k

2022–2025 · research · R21

Leveraging Machine Learning Techniques to Elucidate Risk for Callous-Unemotional Traits

Nicholas J Wagner · Charles River Associates · funded by National Institutes of Health

$197.4kPsychopathy, Forensic Psychiatry, Sexual Offending

2022–2025 · research · R00

Developmental Engagement of Neural Circuitry Underlying Safety Learning

Heidi Catherine Meyer · Charles River Associates · funded by National Institutes of Health

$249kMemory and Neural Mechanisms

2022–2027 · research · R00

Neural Mechanisms of Spatial Representations Beyond the Self

Matthias Stangl · Charles River Associates · funded by National Institutes of Health

$241.4kMemory and Neural Mechanisms

2022–2025 · grant · DP2

Probing functioning lung at the cellular resolution in health and disease

Hadi Tavakoli Nia · Charles River Associates · funded by National Institutes of Health

$1.5M

2022–2027 · research · R01

Arthroscopic Raman Monitoring of Cartilage Content for PTOA Diagnosis and Chondroregenerative Treatment Response

Michael B Albro · Charles River Associates · funded by National Institutes of Health

$584kOsteoarthritis Treatment and Mechanisms

2022–2026 · research · R01

Optimization and validation of quantitative birefringence microscopy for assessment of myelin pathologies associated with cognitive impairments and motor deficits in young and old aging monkey brain

Irving J. Bigio · Charles River Associates · funded by National Institutes of Health

$569.1k

2022–2027 · research · R01

Linking motor cortex activity and movement in the mouse orofacial system.

Michael Nicholas Economo · Charles River Associates · funded by National Institutes of Health

$412.5k

2022–2025 · research · R21

Sub-millimeter precision wireless neuromodulation using a microwave split ring resonator

Ji-Xin Cheng · Charles River Associates · funded by National Institutes of Health

$206.3k

2022–2027 · research · R01

Neurophotonic Advances for Mechanistic Investigation of the Role of Capillary Dysfunction in Stroke Recovery

David A Boas · Charles River Associates · funded by National Institutes of Health

$662.2k

2022–2027 · research · R01

Programmable benchtop bioreactors for scalable eco-evolutionary dynamics of the human microbiome

Ahmad Samir Khalil · Charles River Associates · funded by National Institutes of Health

$867.6k

2022–2027 · research · R01

Neural Markers of Treatment Mechanisms and Prediction of Treatment Outcomes in Social Anxiety

Daniel G Dillon · Charles River Associates · funded by National Institutes of Health

$843.8kAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes